O'Connor HJ - Search Results

1

Impact of Helicobacter pylori on the management of dyspepsia in primary care.

Bennett K, Feely J, Thornton O, Dobson M, O'Morain CA, O'Connor HJ. Bennett K, et al. Aliment Pharmacol Ther. 2006 Aug 15;24(4):637-41. doi: 10.1111/j.1365-2036.2006.03027.x. Aliment Pharmacol Ther. 2006. PMID: 16907896

2

Therapy of Helicobacter pylori.

McLoughlin R, Racz I, Buckley M, O'Connor HJ, O'Morain C. McLoughlin R, et al. Helicobacter. 2004;9 Suppl 1:42-8. doi: 10.1111/j.1083-4389.2004.00251.x. Helicobacter. 2004. PMID: 15347305 Review.

3

Eradication of Helicobacter pylori: recent advances in treatment.

McLoughlin RM, O'Morain CA, O'Connor HJ. McLoughlin RM, et al. Fundam Clin Pharmacol. 2005 Aug;19(4):421-7. doi: 10.1111/j.1472-8206.2005.00340.x. Fundam Clin Pharmacol. 2005. PMID: 16011728 Review.

4

Helicobacter pylori gastritis, the unifying concept for gastric diseases.

Egan BJ, Holmes K, O'Connor HJ, O'Morain CA. Egan BJ, et al. Helicobacter. 2007 Nov;12 Suppl 2:39-44. doi: 10.1111/j.1523-5378.2007.00575.x. Helicobacter. 2007. PMID: 17991175 Review.

5

Helicobacter pylori eradication: role of individual therapy constituents and therapy duration.

Qasim A, O'Morain CA, O'Connor HJ. Qasim A, et al. Fundam Clin Pharmacol. 2009 Feb;23(1):43-52. doi: 10.1111/j.1472-8206.2008.00635.x. Epub 2009 Jan 10. Fundam Clin Pharmacol. 2009. PMID: 19207543 Review.

6

Pylera for the eradication of Helicobacter pylori infection.

Saleem A, Qasim A, O'Connor HJ, O'Morain CA. Saleem A, et al. Among authors: o connor hj. Expert Rev Anti Infect Ther. 2009 Sep;7(7):793-9. doi: 10.1586/eri.09.55. Expert Rev Anti Infect Ther. 2009. PMID: 19735221 Review.

7

Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.

Qasim A, Sebastian S, Thornton O, Dobson M, McLoughlin R, Buckley M, O'Connor H, O'Morain C. Qasim A, et al. Aliment Pharmacol Ther. 2005 Jan 1;21(1):91-6. doi: 10.1111/j.1365-2036.2004.02210.x. Aliment Pharmacol Ther. 2005. PMID: 15644050

8

Analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status?

Taneike I, Nami A, O'Connor A, Fitzgerald N, Murphy P, Qasim A, O'Connor H, O'Morain C. Taneike I, et al. Aliment Pharmacol Ther. 2009 Oct;30(7):784-90. doi: 10.1111/j.1365-2036.2009.04095.x. Epub 2009 Jul 9. Aliment Pharmacol Ther. 2009. PMID: 19604178

9

Review article: test and treat or test and scope for Helicobacter pylori infection. Any change in gastric cancer prevention?

Mc Loughlin RM, Sebastian SS, O'Connor HJ, Buckley M, O'Morain CA. Mc Loughlin RM, et al. Aliment Pharmacol Ther. 2003 Jun;17 Suppl 2:82-8. doi: 10.1046/j.1365-2036.17.s2.13.x. Aliment Pharmacol Ther. 2003. PMID: 12786618 Review.

10

Treatment of Helicobacter pylori.

Egan BJ, Katicic M, O'Connor HJ, O'Morain CA. Egan BJ, et al. Helicobacter. 2007 Oct;12 Suppl 1:31-7. doi: 10.1111/j.1523-5378.2007.00538.x. Helicobacter. 2007. PMID: 17727458 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters